TOP TIERMARKET NEWSWIRE
News & sentiment

ROCKET PHARMACEUTICA (RCKT) — News & AI sentiment

ROCKET PHARMACEUTICA (RCKT) news roundup. 3 stories aggregated over the last 30 days. Average 30-day sentiment is 55.7/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 6 sales totalling $176K — net selling of $176K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
3
avg sentiment 55.7/100
Insider net (90d)
$176K
0 buys · 6 sells
Congress (90d)
0
0 buys · 0 sells

RCKT news in the last 24 hours, 7 days, 30 days and 90 days

How much RCKT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowRCKT storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days355.7/100RCKT headlines →
Last 90 days1856.3/100RCKT headlines →

Latest stories on RCKT

Sep 3
Chardan assumes Rocket Pharmaceuticals stock coverage with buy rating
Investing.com Analyst Ratings61 · neutralanalyst
Sep 1
Aug 27
Aug 12
Aug 11
Aug 10
Aug 10
Aug 10
Aug 10
Rocket Pharmaceuticals stock rating held at Hold by TD Cowen
Investing.com Analyst Ratings50 · neutralanalyst
Aug 3
Why is Rocket Pharmaceuticals stock volatile today?
Investing.com Markets50 · neutralgeneral
Aug 3
Aug 3
Aug 3
Aug 3
Jul 29
Jul 16
Jun 30
Jun 25
Jun 12
Jun 12
Jun 12
Jun 12
Jun 9
Jun 5
May 28
Open RCKT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →